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A B S T R A C T   
Hypericum is a genus of flowering plants and presents a nearly worldwide distribution. The relevance of its 
species is mainly based on the occurrence of specialised secondary metabolites exhibiting a wide range of 
pharmaceutical and cosmeceutical properties. The most well-reported species in the last decade is H. perforatum, 
together with its exceptional polycyclic polyprenylated acylphloroglucinols metabolites. Several inhibitory 
enzyme properties such as anti-tyrosinase, anti-hyaluronidase, anti-collagenase, and anti-elastase, along with the 
relevant cosmeceutical anti-inflammatory and antimicrobial activities, have been reported in numerous bio-
logical studies concerning this genus. From 2010 to date were published more than 3000 articles; therefore, an 
updated summary of Hypericum species and their related cosmeceutical bioactive compounds is necessary. This 
detailed analysis will be mainly focused on cosmeceutical-related bioactivity, phytochemical composition, and 
the products and processes that have been developed using the generated knowledge. Despite all the progress 
made in recent years, which contributed to a state-of-the-art improvement, only a few studies regarding the 
genus have been dedicated to investigating the mechanisms of action and the safety (toxicology) of its bioactive 
compounds using well-validated methodologies. A strategic partnership between R&D and vital cosmeceutical 
enterprises could be the requisite to promote the development of a higher number of efficient and marketable 
Hypericum-derived cosmeceutical products.   
1. Introduction 
The ancient science of cosmetology is believed to have its origins in 
Egypt and India, as the earliest documented practises using cosme-
ceuticals date back to the Indus valley civilization, circa 2500 and 1550 
B.C (Charles Dorni et al., 2017). The term cosmeceutical is commonly 
used to define a cosmetic product with active ingredients promoting 
drug-like benefits (Dominguez et al., 2017; Lee, 2016). They are applied 
topically and include creams, lotions, and ointments, functionalised 
with active compounds known to influence the biological function of the 
skin by supplying the needed antioxidants while improving its appear-
ance, radiance, texture, and anti-ageing activity (Lee, 2016; Taofiq et al., 
2016a). Plant-derived compounds have been extensively used for cos-
meceutical applications, mainly due to the investigation of the active 
principles behind their traditional practices (Charles Dorni et al., 2017). 
These investigations have led to the publication of an endless number of 
studies describing the science behind the uses of flowers, seeds, roots, 
leaves, twigs, and berries from plants distributed worldwide (Charles 
Dorni et al., 2017; Lee, 2016). The rising demand for natural products is 
also the result of increased awareness among consumers, not only 
related to lifestyle issues and their impact on health and well-being, but 
also sustainability concerns regarding the origin, safety, and environ-
mental implications of some of the ingredients used in food, nutra-
ceuticals, and cosmetics formulations (Antognoni et al., 2017; Bilal and 
Iqbal, 2019). Accordingly, the global natural cosmetic market size was 
estimated at 34.12 Billion USD in 2018, and it is predicted to grow at an 
estimated rate of 5.01 % from 2019 to 2025 (“Natural Cosmetics Market 
Size, Share, Trends | Industry Report, 2025,” 2019). 
The genus Hypericum (Hypericaceae) is one of the 100 largest genera 
within the angiosperms clade, encompassing over 500 species, which 
are quite variable in form and habitat, occurring as trees, shrubs, an-
nuals, and perennials (Cirak et al., 2016). Although globally distributed, 
Hypericum specimens are generally absent from the poles, deserts, and 
low-altitude tropical areas (Nürk and Crockett, 2011). The healing 
properties of many of its species are well known and have been mainly 
attributed to its phytochemicals, namely naphthodianthrones (hypericin 
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and pseudohypericin), phloroglucinols (hyperforin), flavonoids (rutin, 
hyperoside, isoquercitrin, quercitrin, quercetin, amentoflavone), and 
phenylpropanoids (chlorogenic acid) (Cirak et al., 2016; Marrelli et al., 
2016). These molecules are behind a great variety of identified bio-
activities: antiaging; anti-inflammatory; antimitogenic; antiviral; anti-
retroviral; antibacterial; antidepressant; photodynamic; and antitumor; 
among others (Cirak et al., 2016). Although the most extensively studied 
species within this genus is Hypericum perforatum L., significant attention 
has been given to some other species, which have been studied regarding 
their phytochemical composition and related biological activities 
(Marrelli et al., 2016). The present systematic review intends to criti-
cally examine how Hypericum species were evaluated, and summarise 
the most relevant cosmeceutical data published over the past decade to: 
provide an overview of the different Hypericum species and their 
bioactive composition; describe which Hypericum species (and related 
metabolites) have been explored as skincare ingredients; identify their 
bioactive properties closely linked to skincare treatments; present a 
systematic assessment of the in vivo studies conducted using formula-
tions containing compounds from different Hypericum species; describe 
the safety and toxicity assessment of Hypericum-derived ingredients used 
as cosmeceuticals; provide an overview of patents and commercial 
products; and identify future trends and challenges associated with the 
genus derived cosmeceutical products. 
2. Ethnobotanical uses of the most common species 
2.1. Hypericum androsaemum L 
H. androsaemum L. (Guttiferae) is a Mediterranean medicinal small 
evergreen shrub occurring in woods dominated by chestnut and oak 
trees, also known as shrubby St. John’s Wort or “Tutsan”, meaning ‘tout- 
saine’, i.e. ‘all-heal’, the name was given for its supposed medicinal 
properties (Valentão et al., 2004). Contrasting to the majority of 
Hypericum species, which exhibit a dry capsule as a fruit, 
H. androsaemum produces fleshy berry-like capsules, which turn from 
red to black as they mature (Antognoni et al., 2017). Another differen-
tiating characteristic of this species is the absence of dark leaf nodules, 
the secretory structures in which naphtodianthrones are synthesized 
(Crockett and Robson, 2011), resulting in plant extracts devoid of 
hypericin and its derivatives (Nabavi et al., 2018). In Portugal it is 
known as ‘Hipericão do Gerês’ and has been used for its diuretic, hep-
atoprotective, and antidepressant effect (Antognoni et al., 2017). Simi-
larly, in Spanish folk medicine, H. androsaemum has been used as an 
antidepressant and anxiolytic (Nabavi et al., 2018), whereas in England 
it has been traditionally used to prepare ointments to treat cuts and 
wounds (Antognoni et al., 2017). 
2.2. Hypericum grandifolium Choisy 
H. grandifolium, also commonly known as ‘malfurada’, is an endemic 
species of Azores, Madeira, and the Canaries islands (Rabanal et al., 
2002; Sánchez-Mateo et al., 2009). Although prevalent in the Maca-
ronesia region, was also introduced in Australia, New Zeeland, Califor-
nia, Hawaii island, and South Africa. It is an evergreen shrub up to 1.8 m 
in height, with dark green leaves, and bright yellow flowers up to 4.5 cm 
broad growing in woods as shown in Fig. 1(ii). H. grandifolium and other 
Hypericum species were used in the folk medicine in the Canary Islands 
as a vermifuge, diuretic, wound healing, as well as sedative, 
anti-hysteric, tranquillizer, and antidepressant agents (Darias et al., 
1986; Wu et al., 2013). 
2.3. Hypericum monogynum L 
H. monogynum is a semi-evergreen shrub with narrow leaves and 
approximately 6 cm wide flowers containing visible golden stamens 
from summer to autumn Fig. 1(iii). Although widely cultivated in South 
Africa, east and southern Asia, Australia, Central America, north-west 
Europe, and Mauritius, it is mainly distributed throughout China and 
some places of Japan (Ernst, 2003; Li et al., 2020; Tanaka and Takaishi, 
2006). As a traditional folk medicine, this plant has been used for the 
treatment of dysmenorrhea and other female disorders, cough, hyper-
tension, hepatitis, acute laryngopharyngitis, pertussis, conjunctivitis, 
rheumatic arthritis, bites of venomous animals, and blunt trauma 
(Tanaka et al., 2005; Tanaka and Takaishi, 2006; Zhang et al., 2020). 
Besides been widely utilised in Chinese folk medicine to treat various 
diseases, it is also cultivated as a landscape plant due to its attractive 
yellow flowers (Xu et al., 2015). 
2.4. Hypericum origanifolium Willd 
H. origanifolium is a herbaceous perennial endemic species to Turkey, 
Armenia, and Georgia (Yaşar et al., 2013), which grows in grassy 
communities of rocky hills. Its stems are 5–30 cm long, branching, and 
sometimes rooting at the base; the leaves are opposite, ovate or obovate, 
5–30 mm in height, with intramarginal and sometimes superficial black 
glandular dots. This species has numerous golden yellow coloured 
flowers, forming a broadly paniculate, almost corymbose inflorescence. 
Its flowers consist of five yellow petals, five green sepals, three styles, 
and numerous stamens (Çirak et al., 2007). H. origanifolium has great 
pharmaceutical potential due to its well-documented phenolic and 
Fig. 1. (i) H. androsaemum (author: Isabel Garcia-Cabral - Botanical Garden 
UTAD); (ii) H. grandifolium (Botanical Garden Canario Viera y Clavijo - file 
licensed under the Creative Commons Attribution-Share Alike 4.0 International 
license); (iii) H. monogynum (adapted from coniferconifer - file licensed under 
the Creative Commons Attribution 2.0 Generic) (iv) H. perforatum L. (Botanical 
Garden UTAD; (v) H. sampsonii (Kyoto Botanical Garden). 
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hypericin content (Çirak et al., 2007; Ozen et al., 2005). Even though 
studies have exploited the phytochemical composition of 
H. origanifolium, details of their pharmacological properties are scarcely 
available (Bertoli et al., 2015; Yaşar et al., 2013). H. origanifolium has 
recently been considered as a potential substitute of H. perforatum in the 
well-established EU market due to its potential biological properties 
(Boran, 2018). 
2.5. Hypericum perforatum L 
H. perforatum has a rich historical background, being one of the 
oldest used and most extensively investigated medicinal herbs. Popu-
larly termed as St. John’s wort, it is an herbaceous perennial flowering 
plant native from Europe, but widely cultivated in temperate regions of 
Asia, North Africa, North America, and Australia. It usually prospers in 
poor soils and is found in meadows, fields, waste areas, and roadsides 
(Galeotti, 2017; Klemow et al., 2011; Öztürk et al., 2007). H. perforatum 
consists of freely branching shrubby herbs, the stems and branches are 
densely covered by oblong, smooth-margined leaves that range from 1 to 
3 cm long and 0.3–1.0 cm wide. The upper portions of mature plants can 
produce several dozen five-petaled yellow flowers, which edges are 
usually covered with black dots. During late summer, the flowers pro-
duce capsules containing dark-brown seeds (Klemow et al., 2011). As a 
herbal remedy known since Greek and Roman times, H. perforatum has 
been used to treat: ulcers; diabetes mellitus; common cold; gastroin-
testinal disorders; jaundice; hepatic and biliary disorders; hemoptysis; 
hematemesis; metrorrhagia; traumatic haemorrhage; irregular 
menstruation; acute mastitis; sore throat; swelling and pain of the eye; 
urinary tract infection; sore furuncle; burns; wounds and bruises; and 
rheumatic arthritis (Galeotti, 2017; Klemow et al., 2011; Öztürk et al., 
2007; Süntar et al., 2010; Zhang et al., 2020). 
2.6. Hypericum sampsonii Hance 
H. sampsonii is found by the river Yangtze in southern China, North 
Vietnam, eastern Burma, Myanmar, northeast India, and Japan (Liu 
et al., 2007; Zhang et al., 2017). It is a perennial herb 20–80 cm tall with 
perfoliate leaves; its flowers present 30–42 stamens and are visible be-
tween June and October. As a traditional Chinese medicine, H. sampsonii 
is known as “Yuanbao Cao” and has been used in the treatment of 
haemoptysis, hepatic disorders, epistaxis, metrorrhagia, traumatic hae-
morrhage, menstrual cramps, irregular menstruation, dysmenorrhea, 
acute mastitis, sore furuncle, dysentery, enteritis, snake bite, burn, 
wounds, bruises, arthralgia, myalgia, fever, and various 
inflammation-related diseases (Chen et al., 2014, 2020; Liu et al., 2007; 
Zhang et al., 2020). In Vietnam, it is an important medicinal plant used 
in to treat many diseases such as backache, burns, diarrhoea, and 
swelling, due to its high content in xanthones and benzophenones 
(Nguyen Viet et al., 2019). 
3. Major biologically active components 
The cosmeceutical and pharmaceutical importance of this genus is 
due to the presence of a broad spectrum of specialized bioactive com-
pounds such as naphthodianthrones (Jarić et al., 2018), phloroglucinols 
(Nogueira et al., 2013), flavonoids (Antognoni et al., 2017), phenolic 
acids, and related compounds (López et al., 2016). A minute amount of 
other biomolecules such as tannins, xanthones, triterpenes, and volatile 
organic compounds have also been reported to be present in some 
Hypericum species (Ersoy et al., 2019). 
3.1. Naphthodianthrones 
Typically found in Hypericum species, naphthodianthrones are 
compounds characterised by intense red colour and exhibiting several 
biological properties mediated by different mechanisms of action (Germ 
et al., 2010; Mansour et al., 2014; Süntar et al., 2011). Hypericins are the 
most well-reported compounds of this class. The two proto-derivatives 
protohypericin and pseudoprotohypericin, have also been found in 
several Hypericum species, but due to their unstable nature are easily 
converted to hypericin and pseudohypericin, respectively (Saddiqe 
et al., 2010). Hypericin and pseudohypericin, shown in Fig. 2(iii) and 
(vi), were first isolated from H. perforatum L., considered the most 
commercially relevant representative of the genus. These compounds 
are most abundant in flowers and leaves, with concentrations ranging 
from 0.03 % to 0.3 % of dry weight, which can significantly vary 
depending on the developmental stage of the plant, cultivar, altitude, 
light conditions, origin, and season (Karioti and Bilia, 2010). 
H. perforatum flowering plants from Lithuania showed between 
770–1990 μg hypericin/g DW (Bagdonaitž et al., 2010), while samples 
from Slovakia presented a lower amount, 50 μg hypericin/g DW (Dresler 
et al., 2018). Although naphthodianthrones show limited solubility in 
almost all solvents, pseudohypericin presents higher solubility in polar 
solvents, which is mainly attributed to the presence of an additional 
hydroxymethyl moiety (Saddiqe et al., 2010). Higher solubility of 
hypericin and pseudo-hypericin has been associated with the addition of 
potassium salts during the extraction process. This mechanochemical 
treatment also increases the dissolution rates, which allow higher 
extraction yield of the active substances (Karioti and Bilia, 2010; 
Lomovsky et al., 2017). 
3.2. Phloroglucinols 
The phloroglucinols are among the most prominent secondary me-
tabolites of the Hypericum genus, being the polycyclic polyprenylated 
acylphloroglucinols (PPAPs), formed by the hybridization of the 
mevalonate/methylerythritol phosphate and polyketide biosynthetic 
pathways, the most abundant compounds (Ye et al., 2020). They exhibit 
fascinating chemical structures, with well-reported biological activities, 
such as anti-HIV, antidepressant, antibacterial, antimalarial, antioxi-
dant, anti-neurodegenerative, antiulcer, wound healing, and 
anti-inflammatory (Zhou et al., 2014). The bicyclic prenylated phlor-
oglucinol derivative hyperforin, represented in Fig. 2(v), is one of the 
main bioactive compounds present in Hypericum species. It is mainly 
distributed in their reproductive parts, approximately 2% in the flowers, 
4.4 % in the ripe fruits, and 4.5 % in the unripe fruits (Saddiqe et al., 
2010). This compound is highly lipophilic, sensitive against air oxida-
tion, and unstable in most organic solvents (Füller and Müller-Goymann, 
2018). Similarly, many meroterpenoids presenting impressive chemical 
structures biogenetically related to prenylated acylphloroglucinols, such 
as Hyperinoids A and B, and Hyperbeanols A, B, and F, have been 
identified in some Hypericum species (Jia et al., 2019; Li et al., 2019a; Xu 
et al., 2019). 
3.3. Phenolic compounds 
3.3.1. Phenolic acids and related compounds 
Among the various phenolic acids found in Hypericum species, 
chlorogenic acid is the most abundant and widely identified (Kladar 
et al., 2015; Tusevski et al., 2014). Other phenolic acids such as ferulic, 
cryptochlorogenic, neochlorogenic, quinic, 3-p-coumaroylquinic, gallic, 
caffeic, sinapic and 3-feruloylquinic acid, have also been identified in 
H. richeri, H. perforatum, H. lanuginosum, H. perfoliatum, H. barbatum, 
H. japonicum, H. hirsutum, H. androsaemum, and H. acutum species (Celep 
et al., 2017; Mahomoodally et al., 2019; Nabavi et al., 2018; Zdunic 
et al., 2017). These compounds are responsible for the hepatoprotective 
properties, anti-depressive-like effects, and the in vivo antioxidant ac-
tivity (López et al., 2016; Nabavi et al., 2018), associated with most 
Hypericum species. 
3.3.2. Flavonoids 
Flavonoids are also among the most significant group of biologically 
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active molecules in Hypericum species, representing up to 2–4% in some 
H. perforatum extracts. The most widely identified flavonoids in Hyper-
icum species with well-documented biological activities include 
kaempferol, luteolin, myricetin, apigenin, quercetin, rutin, quercitrin, 
isoquercitrin, and biapigenin, among others (Mahomoodally et al., 
2019; Nabavi et al., 2018; Napoli et al., 2018). They have attracted 
much interest in recent years due to their well-reported contribution to 
the cosmeceutical properties of some Hypericum species (Antognoni 
et al., 2017; Ersoy et al., 2019). These compounds, mainly present in the 
leaves, flowers, and fruits, have also been reported to possess strong UV 
absorbing properties and can mitigate the effects of free radicals (Germ 
et al., 2010). 
3.3.3. Other minor phenolics 
Xanthones are present in some Hypericum species and have been 
reported to be among the most important contributors to the cytotoxic, 
antioxidant, antimicrobial, and anti-inflammatory activities (Li et al., 
2013; Zhang et al., 2020). Some common xanthones and their associated 
derivatives include: mangiferin, garcinone C and E, banaxanthone E, 
mangostin isomer, neolancerin, ferrxanthone, brasilixanthone B, and 
trihydroxy-1-methoxy-C-prenyl (Li et al., 2013; Tusevski et al., 2014). 
Recently, increasing attention has been given to these compounds due to 
their monoamine oxidase inhibitory effect and their pharmaceutical 
potential as an antidepressant drug (Carradori et al., 2014; Takao et al., 
2019). 
Tannins are one of the most structurally diverse polyphenols present 
in plants and have been reported to play a vital role in plant defence 
against microbial pathogens, herbivores, and climatic changes (Silva 
et al., 2020). Compounds such as gallotannins and tannic acid have been 
associated with the anti-hyaluronidase activity in Hypericum plants due 
to tannins well-known strong protein interaction (Ersoy et al., 2019). 
4. Hypericum species cosmeceutical properties 
Numerous extracts and isolated compounds obtained from Hyper-
icum species have been investigated as ingredients for cosmeceutical 
development. The interactions between cosmeceuticals and skin are 
complex, depending on the selected concentration of the bioactive 
components, condition of the skin, absorption, as well as external 
environmental conditions (Gao et al., 2008). Therefore, in-depth studies 
to evaluate the multifunctional cosmeceutical properties of the active 
molecules, together with the disclosure of the mechanism of action, 
safety, and stability, are an essential prerequisite for specific cosme-
ceutical products development. The following section reviews the most 
relevant studies regarding Hypericum spp. multifunctional properties. 
4.1. Antioxidant activity 
Free radicals, generated within the natural metabolism of aerobic 
cells, can be defined as atoms, molecules, or ions with unpaired elec-
trons, which are capable of independent existence. Its odd number of 
electron(s) makes it unstable, short-lived, and highly reactive. Reactive 
species include both free radicals and some other non-radical com-
pounds of oxygen (ROS) and nitrogen (RNS). These species are gener-
ated during metabolic processes in the mitochondria or peroxisomes; 
through xanthine oxidase activity; inflammation processes; phagocy-
tosis; arachidonate pathway; ischemia; and physical exercise. Smoking; 
environmental pollutants; ultraviolet radiation (UVR); drugs; and pes-
ticides are some examples of external factors that can also promote their 
formation (Barros et al., 2016; Carocho and Ferreira, 2013; Ferreira 
et al., 2009). ‘Primary’ reactive species can interact with other mole-
cules and quickly generate ‘secondary’ reactive species, which 
depending on their final concentration within the cell can cause both, 
oxidative damage or cellular physiological regulation (redox signalling) 
(Barros et al., 2016; Fernández-Moriano et al., 2016; Phaniendra et al., 
2015). Low reactive species levels can directly modulate the activity of 
transcriptional factors, such as NF-κB, p53, NRF2, and induce numerous 
protein kinase cascades that participate in the regulation of the crosstalk 
between autophagy, apoptosis, and regeneration. Moreover, beneath 
physiological conditions, the number of reactive species generated can 
be counterbalanced by external and internal sources of antioxidants. 
Endogenous antioxidant defences can be both non-enzymatic (e.g., uric 
Fig. 2. The most common bioactive compounds found in Hypericum species: (i) chlorogenic acid, (ii) rutin, (iii) hypericin, (iv) hyperoside, (v) hyperforin, (vi) 
pseudohypericin. 
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acid, glutathione, bilirubin, thiols, albumin, and nutritional factors, 
including vitamins, and phenols) and enzymatic (e.g., superoxide dis-
mutase, glutathione peroxidase, and catalase) (Ganceviciene et al., 
2012; Sharma et al., 2015). 
Contrarily to redox signalling, tissue oxidative damage and conse-
quent possible dysfunction is defined as a pathological state in which an 
imbalance between the biochemical processes leading to the production 
of ROS and RNS, and those responsible for its removal, occurs (Di Meo 
et al., 2016; Fernández-Moriano et al., 2016). ROS include species such 
as the hydroxyl radical (OH•), whose reactivity is so high that it reacts 
very close to its site of formation, and other species, such as superoxide 
(O2
• − ) and hydrogen peroxide (H2O2), which are less reactive. RNS 
include nitric oxide (NO●), which is relatively unreactive, and its de-
rivative, the peroxynitrite (ONOO− ), a powerful oxidant, able to damage 
many biological molecules (Barros et al., 2016; Di Meo et al., 2016). 
According to the oxidative damage theory of ageing, it is supposed that 
longevity could be extended by activation of endogenous antioxidant 
defence systems or by exogenous antioxidant supplementation; how-
ever, excessive doses of these substances may be toxic due to their 
pro-oxidative effects at high concentrations or their potential to elimi-
nate beneficial levels of reactive species (Vaiserman et al., 2016). This 
hypothesis supposes that ROS and other reactive species may result in 
damaged molecules such as carbonylated proteins, lipid peroxides, and 
oxidised DNA (Liu et al., 2014; Pinto and Moraes, 2015; Vaiserman 
et al., 2016). 
As an interface organ, the skin is particularly vulnerable to envi-
ronmental insults due to continuous exposure to a complex blend of 
intrinsic and extrinsic ageing processes. Despite the numerous defence 
mechanisms to protect the skin from damage, the efficacy of these di-
minishes over time, resulting in the clinical features associated with 
ageing and in more severe cases, the development of skin cancers. 
Bioactive plant derived-compounds can modulate essential cell pro-
cesses through a vast number of mechanisms of action and interaction 
points across many intracellular signalling cascades (García-Pérez et al., 
2018). Several publications have identified different Hypericum species 
as important sources of antioxidant molecules presenting capacity as 
radical scavengers, metal chelators, and lipid peroxidation inhibitors. 
Some of the most widely utilised antioxidant assays are the DPPH (2, 
2-diphenyl-1-picrylhydrazyl), ABTS (2,20-azinobis 3-ethylbenzothiazo-
line-6-sulfonic acid), FRAP (ferric reducing antioxidant power), 
CUPRAC (cupric ion reducing antioxidant capacity), TBARS (thio-
barbituric acid reactive substances), ORAC (oxygen radical antioxidant 
capacity), DMPD (N,N-dimethyl-p-phenylenediamine dihydrochloride) 
TEAC (Trolox-equivalent antioxidant capacity), and the superoxide 
anion radical scavenging assay. Eleven Hypericum species grown in 
Sicily (H. perforatum, H. aegypticum L., H. androsaemum, H. calycinum L., 
H. hircinum L., H. hirsutum L., H. montanum L., H. patulum, H. perfoliatum 
L., H. pubescens Boiss., and H. tetrapterum Fr.) were reported to have a 
good level of antioxidant/radical scavenging activity, with H. perforatum 
extract (1.03 ± 0.19 mmol Trolox equivalent/g) being the most active 
during the ORAC assay. Moreover, H. aegypticum extract presented the 
best DPPH scavenging activity (0.57 ± 0.24 mmol Trolox equivalent/g) 
(Napoli et al., 2018). Hyperforin and hypericin are the main bioactive 
molecules present across the Hypericum genus. However, other constit-
uents, like the polyphenols, have also been reported to be the main 
responsible for their potent antioxidant properties. Napoli et al. (2018) 
attributed the antioxidant capacities of Hypericum species to their high 
content in polyphenolic compounds like apigenin, amentoflavone, 
quercetin-3-O-glucoside, quercetin-3-O-galactoside, quercitrin, and 
quercetin. Hyperoside and isoquercetin were reported to be the most 
significant contributors to the antioxidant capacity displayed by the 
methanolic extracts prepared from H. capitatum, quantified using the 
DPPH (IC50, 16.82 ± 0.58 μg mL− 1), ABTS (IC50, 9.24 ± 0.28 μg mL− 1), 
and β-carotene bleaching (IC50, 41.69 ± 1.29 μg mL− 1) methods. Eroglu 
Ozkan et al. (2018) obtained a higher antioxidant activity in crude 
methanolic extracts from H. neurocalycinum when compared to 
H. malatyanum. These authors measured DPPH (EC50, 0.251 ± 0.01 mg 
mL− 1), superoxide anion radical scavenging (EC50, 0.613 ± 0.05 mg 
mL− 1), and inhibition of lipid peroxidation (EC50, 2.49 ± 0.09 mg 
mL− 1). DPPH radical scavenging and metal-reducing ability were 
measured using FRAP and CUPRAC tests. The results showed that the 
hydroethanolic extract produced from the aerial parts of H. perfoliatum 
presented strong antioxidant capacities (Celep et al., 2017). Phenolic 
acids such as gallic, chlorogenic, caffeic, and p-coumaric were also 
linked to the radical-scavenging capacity of methanol and 
chloroform-methanolic extracts of H. perfoliatum (Del Monte et al., 
2015). 
Hyperforin is well-known for its anti-inflammatory, anti-tumour, 
anti-bacterial, and antioxidant properties. Haag et al. (2014) reported 
the application of a hyperforin-rich formulation to strengthen the skin 
barrier function. Eleven healthy volunteers (six females, five males, aged 
21–42) were included in this study. After application, VIS/NIR-induced 
radical formation was inhibited up to 45 %. Furthermore, the skin lipid 
profile was investigated, applying HPTLC on skin lipid extracts. The 
lipid profile was found to increase directly after a single cream appli-
cation; only for ceramide and squalene the improvement was significant, 
no relevant increase was observed for cholesterol. These results indicate 
that regular use of the hyperforin-rich cream can reduce the radical 
formation and help stabilize skin lipids, which are responsible for 
maintaining the skin barrier function. Similarly, the radical scavenging 
effect of a formulation containing H. perforatum extract rich in hyper-
forin, in a double-blind placebo-controlled study, was carried out in 11 
healthy volunteers by Arndt et al. (2013). The results showed that 
radical formation could be reduced by almost 80 % when applying the 
hyperforin-rich cream onto the skin. A formulation containing 44.3 % 
hyperforin and free of hypericin was investigated for its in vivo photo-
protective and radical protection capacity (Meinke et al., 2012). Assays 
were also conducted in vitro in HaCaT keratinocytes irradiated with solar 
simulated radiation, and the results showed that hyperforin (EC50, 
0.42 μg mL− 1) was much more effective when compared to trolox (EC50, 
12 μg mL− 1). The radical protection factor of the formulation was found 
to present very high radical scavenging activity (200 × 1014 radicals 
mg− 1). Furthermore, UV erythema test was conducted in twenty-two 
healthy volunteers (4 men and 18 women, aged between 19 and 59 
years) and the formulation was found to significantly reduced 
UVB-induced erythema as opposed to the placebo group. These results 
show that hyperforin is a powerful free radical scavenger and can be 
utilised to suppress the severity of an ageing skin. 
To the authors’ best knowledge, when compared to other biological 
cosmeceutical assays, the antioxidant capacity remains the most widely 
reported among Hypericum species. 
4.2. Anti-ageing activity 
Collagen fibres are the principal structural component of the dermis, 
giving the skin its tensile strength; while elastin fibres contribute to its 
elasticity and resilience (Tobin, 2016). Skin ageing is a process caused 
by intrinsic and extrinsic ageing factors, both responsible for moderate 
to drastic changes in skin structure and elasticity. Intrinsic skin ageing 
represents the “normal” course of ageing of all tissues, strongly associ-
ated with chronological age, genetic influence, and internal factors, such 
as hormones and metabolic substances. In contrast, the extrinsic skin 
ageing process is the result of exogenous factors: sun exposure (photo-
aging), environmental toxins, infectious agents, and miscellaneous 
lifestyle components (i.e. smoking and diet) (Chiocchio et al., 2018; 
Tobin, 2016). 
Histologically, chronologically aged skin exhibits general atrophy of 
the extracellular matrix (ECM) reflected by a decreased in fibroblasts 
number and reduced levels of collagen and elastin. The latter is thought 
to result from both a reduction in protein synthesis affecting mainly 
types I and III of collagen in the dermis and an increased breakdown of 
extracellular matrix proteins (Rittié and Fisher, 2002). Conversely, 
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photoaged skin is described as exhibiting an increased epidermal 
thickness and alterations in tissue organisation; being possible to 
observe the accumulation of amorphous elastin-containing material that 
resides beneath the epidermal-dermal junction (Rittié and Fisher, 2002). 
Oxidative stress is thought to play a central role in initiating and 
driving the signalling events that lead to the cellular response following 
UVR exposure. UV irradiation increases the formation of reactive oxy-
gen species (ROS) and decreases in the skin’s own antioxidant enzymes 
pool. UV activation of growth factor or cytokine receptors leads to the 
activation of extracellular signal-regulated kinase (ERK), c-Jun N-ter-
minal kinases (JNK), and p38 mitogen-activated protein kinases. This 
activation is enhanced by a joint production of ROS, which can increase 
growth factor receptors inhibiting protein tyrosine phosphatases (PTPs) 
and/or directly activating mitogen-activated protein kinase kinases 
(MKKKs). Once activated by MKKKs, mitogen-activated protein kinases 
(MAPKs) can then phosphorylate transcription factors (e.g. Elk-1, c-Jun, 
ATF-2) leading to an increased expression of the transcription factor 
activator protein 1 (AP-1), which results in both upregulation of matrix 
metalloproteinases (MMPs) and down-regulation of procollagen I pro-
duction (Rittié and Fisher, 2002). Similarly to photoaging, during the 
chronological ageing process, increased ROS production alters gene and 
protein structure and function, leading to skin damage, caused by the 
activation of several downstream protein cascades (Chiocchio et al., 
2018; Rittié and Fisher, 2002; Tobin, 2016). 
Although collagen and elastin are the major proteins present in the 
ECM; hyaluronic acid (HA) is also an essential component. HA can hold 
moisture to the skin, contributing its mechanical resistance and flexi-
bility (Boran, 2018). Collagenase, elastase, and hyaluronidase are ECM 
degrading enzymes resultant from reactive species activation through 
different proteins cascades; these enzymes activity compromise skin 
structural integrity, culminating in both photo and chronological skin 
ageing signs. Due to their well-reported anti-collagenase, anti-elastase, 
and anti-hyaluronidase activities, Hypericum species represent a 
largely unexplored source of bioactive molecules that can be utilised to 
develop cosmetic formulations exhibiting antiaging properties (Table 1). 
As shown in Table 1, collagenase and elastase inhibitory activities have 
been reported for several Hypericum species, including H. androsaemum, 
H. ascyron, H. calycinum, H. confertum, H. hircinum L., H. origanifolium, 
and H. perforatum (Antognoni et al., 2017; Boran, 2018; Ersoy et al., 
2019; Li et al., 2019a,b; Mandrone et al., 2015). To the best of the au-
thors’ knowledge, only Ersoy et al. (2019) reported anti-hyaluronidase 
activity for three Hypericum species, namely H. perforatum, 
H. calycinum, and H. confertum. All the plants’ methanolic extracts pre-
sented strong hyaluronidase inhibitory capacities. The majority of the 
findings mentioned above identified polyprenylated acylphloroglucinols 
and phenolic compounds as being the most important contributors to the 
Hypericum species skin ageing enzymes inhibition proprieties. Regarding 
isolated compounds, Li et al. (2019a,b) identified 8 polyprenylated 
acylphloroglucinols through detailed spectroscopic data analysis from 
dried flowers of H. ascyron. The isolated compounds were identified as 
ascyronone E, ascyronone F, ascyronone G, hypelodin B, hypercohin K, 
furohyperforin, hypercohin G, and hyphenrone. All the molecules 
revealed significant dose-dependent inhibition against elastase en-
zymes, with ascyronone E (4.3 ± 0.4 μM) and furohyperforin 
(2.4 ± 0.3 μM) being the most potent. High levels of ROS are known to 
enhance MMPs production and consequent collagen and elastin degra-
dation. Hence, their inhibition may play a vital role in suppressing both 
chronological and UV induced skin ageing signs. Regarding Hypericum 
species, only H. formosanum and H. olympicum have been reported to 
suppress the expression of MMP-1 and MMP-9, respectively, upon 
exposure to UV radiation (Huang and Liaw, 2017; Kurt-celep et al., 
2020). The numerous findings published up-to-the-date showed that 
most Hypericum plants are an essential source of biomolecules that can 
be utilised as additives in cosmetic formulations to suppress ageing 
signs. However, a detailed understanding of the mechanism of action 
behind their reported anti-ageing properties is essential to help bridge 
this gap. 
4.3. Anti-tyrosinase activity 
Skin pigmentation is the consequence of the melanin synthesis in 
melanocytes. Tyrosinase is the rate-limiting enzyme during melanin 
pathway biosynthesis, catalysing three different reactions that lead to 
the formation of eumelanin (brown-black pigment) and pheomelanin 
(yellow, red pigment) (Taofiq et al., 2016a). The enhanced activity of 
the intermediate tyrosinase enzyme is caused by long term exposure to 
UV radiation, auto-immune conditions, hormonal changes (causing the 
release of α-melanocyte-stimulating hormone), and genetic factors. 
There are several signal transduction pathways responsible for 
increasing melanin production through the regulation of mRNA 
expression of tyrosinase and tyrosinase-related proteins (TRP1 and 
TRP2). Melanin biosynthesis is initiated by the 
microphthalmia-associated transcription factor (MITF), which binds to 
the promoter region of TRP-1 and TRP-2, causing an increase in enzyme 
expression (Huang et al., 2014; Pillaiyar et al., 2017). Hence, there is an 
increased need to discover melanogenesis inhibitors that target various 
signalling steps in the melanin biosynthesis pathways, either directly or 
indirectly. Hyperpigmentation is a skin condition resulting from a 
continuous melanin synthesis, characterised by dark and brown spots, 
and irregular grey patches on the face, neck, and trunk. Compounds such 
as hydroquinone, retinoic acid, and corticosteroids, are the most widely 
utilised to treat hyperpigmentation disorders. However, there are many 
safety concerns regarding their application on the skin, namely their 
potential to be carcinogenic, cause contact dermatitis, 
post-inflammatory hypopigmentation, exogenous ochronosis, cell irri-
tation, and exudation of offensive fish odour from the skin (Chao-
wattanapanit et al., 2017). These adverse effects have resulted in the 
withdrawal of some of these components from the European market (EU 
Cosmetic Regulation 1223/2009). In contrast, some Asian markets still 
allow the use of hydroquinone at lower and presumably safer concen-
trations (Japanese Pharmaceutical Law in 2001) (Ando et al., 2010). 
These concerns have motivated the search for novel ingredients from 
natural sources with the capacity to inhibit one or more steps in the 
melanin biosynthetic pathway, which exhibit a safer profile. The use of 
plant extracts and their derived phytochemicals have shown promising 
potential and have been identified as future hyperpigmentation cor-
recting ingredients (Mukherjee et al., 2018; Silva et al., 2020). Species 
belonging to the Hypericum genus have shown strong tyrosinase inhi-
bition capacity (Table 1). Extracts prepared from H. androsaemum, 
H. calycinum, H. Confertum, H. lanuginosum, H. Perforatum, and 
H. salsugineum have all been reported to show tyrosinase inhibitory ca-
pacities, with their results either expressed in terms of EC50 values or 
kojic acid equivalent (Altun et al., 2013; Bender et al., 2018; Ersoy et al., 
2019; López et al., 2016; Mahomoodally et al., 2019). The tyrosinase 
inhibitory properties of most biomolecules are scientifically validated 
using Kojic acid as a positive control. This fungal metabolite is currently 
used as a cosmetic skin-whitening agent, which displays a competitive 
mode of tyrosinase inhibition. To the author’s best knowledge, only the 
methanolic extracts prepared from the non-flower shoots (NFS) and 
flower shoots (FS) of H. perforatum displayed tyrosinase inhibitory po-
tential that is comparable to kojic acid. The NFS and FS extracts 
inhibited tyrosinase enzyme by 90 % and 87 %, respectively, compared 
to 97 % reported for kojic acid (Tusevski et al., 2018). The methanolic 
extracts of H. olympicum, H. pruinatum, and H. scabrum were reported to 
present excellent tyrosinase inhibition (Llorent-Martínez et al., 2018). 
The most abundant compounds in those extracts were quercitrin, 
hyperoside, myricitrin, chlorogenic acid, and neo-chlorogenic acid. All 
the above compounds were selected for molecular docking simulation 
by the authors. In all cases, the binding pocket and the docking scores 
revealed that chlorogenic acid was the best inhibitor of tyrosinase 
among the tested compounds. Mahomoodally et al. (2019) also identi-
fied chlorogenic acid in H. lanuginosum extracts as the compound 
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Table 1 
Biological properties of different Hypericum species extracts and their isolated metabolites.  
Species Plant parts Country of 
collection 
Active ingredients Biological 
activity 






Polyphenol rich extract Anti- 
inflammatory 
Hydromethanolic extract suppressed NO 
levels in RAW264.7 macrophage cells with 
IC50 value of 22.47 ± 3.87 μg mL− 1. Cell 
viability was maintained in a concentration 
dependent manner. 




Fruit Italy Polyphenol rich extract Anti-collagenase 
Aqueous and methanolic extracts showed 
collagenase inhibitory activity with IC50 
values of 88.2 and 105.95 μg mL− 1, 
respectively. 
(Antognoni et al., 
2017) 
Fruit Italy 




Methanolic extract inhibited proliferation 
of A375 human malignant melanoma cell 
line with an IC50 value of 32.29 μg mL− 1. 
(Caprioli et al., 
2016) 
Fruit Italy Phenolic acids and Flavonoids Anti-tyrosinase 
Methanolic extract showed significant 
tyrosinase inhibitory effect with an IC50, 
value of 229.1 μg mL− 1 
(López et al., 2016) 
Aerial parts Portugal Phenolic acids and Flavonoids 
Anti- 
inflammatory 
Hydroethanolic extract suppressed NO 
levels in RAW264.7 macrophage cells with 
IC50 value of 179 ± 17 μg mL− 1. 
(Jabeur et al., 
2016) 
Fruit Italy Polyphenol rich extract Wound healing 
Aqueous and methanolic extracts at 
10 μg mL− 1 greatly enhanced cell 
migration and showed a decrease in wound 
by 39% and 52%, respectively. 
(Antognoni et al., 
2017) 
Hypericum ascyron 





All isolated compounds were found to 
inhibit elastase activity with IC50 values 
between 2.4–19.9 μM. 




Aerial part China 
Rutin, hyperoside, 
isoquercitrin, and quercetin 
Anti- 
inflammatory 
Ethyl acetate extract up to 300 μg mL− 1, 
inhibited NO, TNF-α, IL-6, and IL-1β levels 
in LPS induced RAW264.7 cells. The 
nuclear translocation of p65, the 
phosphorylation of Erk1/2, p38, and JNK 
were also significantly suppressed. 
(Jin et al., 2019) 
Hypericum beanii 
N. Robson 




Hyperberins A and B showed significant NO 
inhibitory effects in RAW 264.7 
macrophages with IC50 values of 
7.36 ± 0.97 and14.00 ± 0.14 μM, 
respectively 






Hyperbeanol F, H, and O exhibited NO 
inhibitory activities in LPS-induced RAW 
264.7 macrophages, with IC50 values of 
22.31 ± 0.32 μM, 22.68 ± 0.44 μM, and 
19.62 ± 0.48 μM, respectively. 




Aerial part Brazil Phloroglucinols Cytotoxicity 
Hexanic extract and the three isolated 
phloroglucinols: Japonicin A, Uliginosin B, 
and Isouliginosin B inhibited proliferation 
of the UACC-62 human malignant 
melanoma cell line with IC50 values of 2.41, 
93.81, 3.47, and 18.8 μg mL− 1 respectively. 




Aerial part Turkey 




Methanolic extract showed collagenase and 
elastase inhibitory effect with IC50 values of 
51.24 ± 1.33 and 55.77 ± 1.32 μg mL− 1, 
respectively. 
(Ersoy et al., 2019) 
Aerial part Turkey 






Methanolic extract inhibited the 
hyaluronidase enzyme with an IC50 value of 
22.17 ± 0.02 μg mL− 1. At 200 μg mL− 1, the 
extract presented 54% tyrosinase 
inhibition. 
(Ersoy et al., 2019) 
Hypericum 
canariense L. Aerial part Spain Phenolic acids and flavonoids Cytotoxicity 
Methanol–acetone extract inhibited 
proliferation of A375 human malignant 
melanoma cell line with an IC50 value of 
15.78 μg mL− 1. 








PEF at 10 and 15 μg mL-1 showed 
significant increase in HaCaT cell 
proliferation, up to129.4 % and 138.7 %, 
respectively. 
(Bridi et al., 2017) 
Aerial part Brazil Phloroglucinols derivatives 
Proliferative 
effect 
Cariphenone B at 0.01 μM and 0.1 μM 
showed significant increase in HaCaT cell 
proliferation up to 122.3 % and 114 %, 
respectively. 








Methanolic extract showed collagenase and 
elastase inhibitory effect with IC50 values of 
63.01 ± 0.24 and 61.67 ± 0.76 μg mL− 1, 
respectively. 
(Ersoy et al., 2019) 
Aerial part Turkey (Ersoy et al., 2019) 
(continued on next page) 
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Table 1 (continued ) 
Species Plant parts Country of 
collection 
Active ingredients Biological 
activity 
Bioactive effects References 






Methanolic extract inhibited hyaluronidase 
enzyme with an IC50 value of 
36.55 ± 0.11 μg mL-1. At 200 μg mL− 1, 




Whole plant nm Hyperoside, astilbin, 
quercitrin, and quercetin 
MMP-1 inhibitory 
activity 
Hydroethanolic extract reduced matrix 
metalloproteinase-1 protein expression in 
human skin keratinocyte cells up to 
66 ± 2.3 % at 500 μg mL− 1. 




Flower stems USA Uliginosin A, saroaspidin A, 
hyperbrasilol A, chlorogenic 




Ethanolic extracts at 10 μg mL− 1, 
suppressed NO and PGE2 levels LPS- 
induced RAW 264.7 mouse macrophage 
cells. 





Aerial part Spain Phenolic acids and flavonoids Cytotoxicity Methanol–acetone extract inhibited 
proliferation of A375 human malignant 
melanoma cell line with an IC50 value of 
7.12 μg mL− 1. 




Aerial part Italy Polyphenol rich extract Anti-collagenase Ethanolic extract displayed in-vitro 
collagenase activity, with an IC50 value of 
156.0 μg mL− 1. 






Whole plant Nepal Flavonoids, phloroglucinols 
and phenolic acids 
Anti- 
inflammatory 
Methanolic extract at 2 μg mL− 1 
significantly decreased the expression of 
both NF-ĸB and AP-1. 
(Peron et al., 2019) 
Hypericum 
lanuginosum L. 
Aerial part Turkey Polyphenol rich extract Anti-tyrosinase Ethyl acetate, Methanol and Aqueous 
extract showed significant tyrosinase 
inhibitory effect with IC50 of 
260.40 ± 2.10, 276.34 ± 2.42, and 
118.85 ± 3.44 mg KAE/g, respectively. 
(Mahomoodally 








Hypermongone A, F, G, and H, exhibited 
moderate nitric oxide (NO) inhibitory 
activities in LPS-induced RAW 264.7 
macrophages, with IC50 values of 14.5, 
15.2, 9.5, and 14.9 μM respectively, 






Furanmonogones A at 50 μM showed 63.17 
% inhibitory effect on NO production in the 
LPS-induced RAW 264.7 cells. 
(Xu et al., 2017) 
Hypericum 
olympicum L. 
Aerial part Turkey 
Chlorogenic acid Rutin 




Hydromethanolic at 1.5 mg mL− 1 
maintained cell viability of Human Dermal 
Fibroblast (HDF) and provided a 
remarkable inhibition of MMP–9 activity, 
after 48 h exposure to UV radiation (0.5 J/ 
cm2). 
(Kurt-celep et al., 
2020) 
Aerial part Turkey 
Phenolic acids, Flavonols and 
Flavones Anti-tyrosinase 
Methanolic extract showed tyrosinase 
inhibitory effect with IC50, 
60.95 ± 1.10 mg KAE/g extract 
(Llorent-Martínez 




Aerial part Turkey Polyphenol rich extract Anti-collagenase 
Ethanolic extract at 1000 μg mL− 1, 
inhibited collagenase (79.39 ± 0.12), 
elastase (56 ± 0.20) and hyaluronidase 








Hypatulone A exhibited NO inhibition 
activitiy in LPS-induced RAW 264.7 
macrophages, with an IC50 value of 
18.8 ± 1.75 μM. 
(Liu et al., 2018) 
Aerial parts China Prenylated acylphloroglucinols 
Anti- 
inflammatory 
Hyperinoids A and B showed significant 
inhibitory activities against the NF-kB 
pathway, with IC50 values of 0.75 ± 0.17 
and 1.19 ± 0.48 μmol/L, respectively. The 
cell viability of the RAW 246.7 cells were 
maintained at the above tested 
concentration. Both compounds also 
suppressed mRNA expression of IL-1β, IL-6, 
and iNOS. 
(Jia et al., 2019) 
Hypericum 
perforatum L. 
Aerial part Turkey 






Methanolic extract inhibited hyaluronidase 
enzyme with an IC50 values of 
37.30 ± 1.49 μg mL− 1. At 200 μg mL− 1, the 
extract presented 48% tyrosinase inhibition 
(Ersoy et al., 2019) 
Aerial part Turkey Hypericin Wound healing 
Macroscopic and histopathological 
examination showed that the extract 
provided significant efficacy for the 
treatment of pressure sore wounds with 
reduction in total wound area by 37.6 % 
(109 ± 29 cm2 to 69 ± 23 cm2). 
(Yücel et al., 2017) 
Root in vitro 
cultures 
Germany Petroleum ether extract Proliferative 
effect 
Hyperforin rich extract reduced the 
viability of HaCaT and HDF monolayers to 
(Gaid et al., 2019) 
(continued on next page) 
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Table 1 (continued ) 
Species Plant parts Country of 
collection 
Active ingredients Biological 
activity 
Bioactive effects References 
33 % and 36 %, respectively, No cytotoxic 
effects were observed. 
Flowers Turkey Polyphenol rich extract Anti-tyrosinase Methanolic extract at 250 μg mL− 1 showed 
19.21 ± 1.44% inhibition towards 
tyrosinase, 
(Altun et al., 2013) 
Aerial part Turkey Hyperoside, isoquercitrin, 
rutin (-)- Epicatechin and 
hypericin 
Wound healing Oil extract showed significant wound 
healing effect on excision (5.1–82.6 % 
inhibition) and circular incision 
(20.2–100.0 % inhibition). Moreover, 
presenting dose-dependent anti- 
inflammatory activity. 
(Süntar et al., 
2010) 
Aerial part USA Amentoflavone, quercetin, 
chlorogenic 
acid and pseudohypericin 
Anti- 
inflammatory 
Extract fraction suppressed LPS-induced 
prostaglandin E2 (PGE2) production in 
RAW 264.7 mouse macrophages due to 
suppression of Janus kinase and signal 
transducer and activator of transcription 
(JAK–STAT) expression. 







Macedonia Chlorogenic acid 
Flavan-3-ols, Hyperoside, 
Rutin, hyperforins and 
hypericins 
Anti-tyrosinase The tyrosinase inhibitory activity was 87 
%, 90 % and 69 % for extract prepared from 
FS, NFS and RO, respectively. Compared to 
97 % reported for kojic acid. 
(Tusevski et al., 
2018) 







Ethanolic extracts at 10 μg mL− 1 
suppressed NO and PGE2 levels in LPS- 
induced RAW 264.7 mouse macrophage 
cells. 
(Huang et al., 
2011) 
Aerial part Italy Hyperforin, chlorogenic acid 
and, hyperoside 
Wound healing Methanol-acetonic extract caused an 
increase in cell migration, proliferation, 
contraction, and collagen production in 
NIH3T3 mouse fibroblast cells. 
(Dikmen et al., 
2010) 




Methanolic extract showed collagenase and 
elastase inhibitory effect with IC50 values of 
61.53 ± 0.40 and 64.76 ± 0.55 μg mL− 1, 
respectively. 
(Ersoy et al., 2019) 
Hypericum 
pruinatum Boiss. 
& Balansa ex 
Boiss. 
Aerial part Turkey Phenolic acids, Flavonols and 
Flavones 
Anti-tyrosinase Methanolic extract showed tyrosinase 
inhibitory effect with an IC50 value of 
65.35 ± 1.18 mg KAE/g extract. 
(Llorent-Martínez 
et al., 2018) 
Hypericum 
reflexum L.f. 
Aerial part Spain Phenolic acids and flavonoids Cytotoxic Methanol–acetone extract inhibited 
proliferation of A375 human malignant 
melanoma cell line with an IC50 value of 
14.01 μg mL− 1. 




Robson & Hub.- 
Mor. 
Aerial part Turkey Phenolic acids and flavonoids Anti-tyrosinase 
and Wound 
healing 
Methanolic extract showed tyrosinase 
inhibition with IC50 value of 
65.29 ± 0.41 mgKAE/g. In vitro wound 
healing scratch assay showed significant 
healing progression between 0− 48 h after 
exposure to extract at 350 μg mL− 1. 




Whole plant China 
Anthraquinonoids, 
phloroglucinol, and flavonoids 
Anti- 
inflammatory 
Emodin (12.39 ± 1.00 μM), 3-ethyl-1,8- 
dihydroxy-6 methoxyanthracene-910- 
dione (14.11 ± 0.43 μM), hyperforatin F 
(13.05 ± 0.42 μM), and quercetin 
(10.59 ± 0.55 μM) suppressed NO 
production in LPS-induced RAW 264.7 
macrophages, with IC50 values more 
effective than indomethacin 
(15.20 ± 1.10 μM). 
(Chen et al., 2020) 
Whole plant China Anthraquinonoids and 
phloroglucinol 
Cytotoxicity 
Among the 25 compounds isolated, emodin 
(8.56 ± 0.32 μM) and hyperforatin F 
(7.52 ± 0.24 μM) were the most effective 
against A375 human malignant melanoma. 
Comparable results to Cisplatin 
(6.61 ± 0.07 μM), a chemotherapy drug 
used against several forms of cancers. 
(Chen et al., 2020) 
Aerial part Vietnam Xanthones and benzophenones 
Anti- 
inflammatory 
Sampsine A, sampsine B, and petiolin F 
suppressed NO production in LPS induced 
RAW264.7 cells with IC50 values of 
2.40 ± 0.69 μM, 2.29 ± 0.12 μM, and 
2.00 ± 0.34 μM, respectively. 
(Nguyen Viet et al., 
2019) 





Norhypersampsone A exhibited moderate 
NO inhibitory activities in LPS-induced 
RAW 264.7 macrophages, with IC50 values 
of 30.2 μM. 
(Zhang et al., 
2017) 
Whole plant China Cytotoxicity (Chen et al., 2020) 
(continued on next page) 
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presenting the best docking pose against the tyrosinase enzyme. Ample 
evidence has suggested that most Hypericum species are important 
sources of biomolecules with interesting tyrosinase inhibitory capac-
ities. Still, findings on the contribution of their isolated compounds have 
not been well exploited. A significant number of the findings on tyros-
inase inhibitors have been conducted using commercial tyrosinase 
enzyme obtained from the Agaricus bisporus L, one of the most widely 
cultivated edible mushroom. Nonetheless, some evidence has shown 
that there are some differences in the inhibition potential of compounds 
against fungal and human tyrosinase, due to their different active site 
oxidative states, substrate specificity, and amino acid sequence (Mann 
et al., 2018; Mukherjee et al., 2018). Hence, further findings should be 
conducted using human tyrosinase to find novel and effective tyrosinase 
inhibition molecules from Hypericum species. 
4.4. Anti-inflammatory activity 
Inflammation is a protective mechanism to remove harmful stimuli 
from the body. The use of anti-inflammatory molecules has been 
employed as an effective treatment to suppress its severity, which is 
often associated with pathogenesis (Taofiq et al., 2016b). In this context, 
bioactive extracts and their compounds are employed worldwide in folk 
medicine to suppress the severity of inflammatory processes, including 
skin inflammations. Hence, there is a continuous search for bio-
molecules with the potential to inhibit the expression of inflammatory 
mediators such as nitric oxide (NO), interleukins (IL 1β, IL-6, IL-8), 
tumour necrosis factor (TNF-α), and prostaglandin E2 (PGE2). The Nu-
clear Factor kappa-light-chain-enhancer of activated B cells (NF-ĸB) is a 
transcription factor that regulates the expression of several inflamma-
tory mediators, which play vital roles in the inflammation process. 
Recent findings have identified natural biomolecules as inhibitors of 
specific steps in the pathway leading to NF-ĸB release (Chen et al., 2016; 
Zhang et al., 2014). In the continuous search for new bioactive mole-
cules against inflammation, some Hypericum species are increasingly 
being referred to as rich sources of such components, especially those 
belonging to the phloroglucinols class (hyperberins, hyperbeanol, 
hypermongone, and furanmonogones) (Li et al., 2019a,b; Xu et al., 
2019, 2017, 2015). Some Hypericum compounds were pointed as both 
suppressors of inflammatory mediators and inhibitors of some specific 
pro-inflammatory enzymes. Concerning the anti-inflammatory potential 
of biomolecules from Hypericum species shown in Table 1, most research 
findings were undertaken to quantify the suppression of different in-
flammatory mediators (interleukins, TNF-α, and NO) in a mouse 
macrophage cell model (RAW 264.7). Other studies utilised different 
test models such as the carrageenan-induced paw oedema in rodents 
(Mansour et al., 2014). To the author’s best knowledge, no findings on 
the anti-inflammatory capacity of extracts from Hypericum species or 
their compounds have been reported against cyclooxygenase (COX) 
enzymes. These enzymes catalyse the rate-limiting step in the biosyn-
thesis of prostaglandins, prostacyclins, and thromboxanes from arach-
idonic acid. There are two major isoforms of the cyclooxygenase 
enzyme: COX-1 forms prostaglandins that perform housekeeping func-
tions and COX-2 forms prostaglandins that are involved in inflamma-
tion. Prostaglandins play a significant role in several biological 
processes, including gastric mucosal protection, thermoregulation, 
platelet aggregation, control of renal blood flow and kidney function 
(Elgorashi and McGaw, 2019; Taofiq et al., 2016b). Contrasting, other 
prostaglandins have been associated with pathological functions such as 
pain, fever, arthritis, asthma, and inflammatory bowel disease. Prosta-
glandin E2 (PGE2) is mainly associated with the pathogenesis of 
different inflammatory diseases. Huang et al. (2011) and Hammer et al. 
(2010) were the only authors reporting Hypericum potential to reduce 
PGE2 levels: H. gentianoides flower and stem ethanolic extract at 10 μg 
mL− 1 and H. japonicum whole plant methanolic extract at 2 μg mL− 1, 
respectively. Mitogen-activated protein kinase (MAPKs) play crucial 
roles in inflammation induction. These family of protein kinases can be 
activated through the phosphorylation of several protein kinases, 
including Erk1/2, p38, and JNK. The mechanism behind the 
anti-inflammatory capacity of most natural biomolecules has been 
associated with the inhibition of the phosphorylation of the 
above-mentioned protein kinases. H. attenuatum ethyl acetate prepared 
using ultrasound-assisted extraction at 300 μg mL− 1, suppressed the 
expression of the pro-inflammatory cytokines TNF-α, IL-6, and IL-1β. 
The effect of the extract on the NF-κB and MAPK signalling pathways 
were also investigated using immunofluorescence assays. The 
polyphenol-rich extract was found to prevent the nuclear translocation 
of p65 and suppress the phosphorylation of Erk1/2, p38 and JNK. To the 
author’s best knowledge, only Peron et al. (2019) reported the in vitro 
inhibition of NF-κB using extracts from Hypericum species. Regarding 
isolated compounds, two polycyclic meroterpenoids (Hyperinoids A and 
B) from H. patulum were reported to significantly inhibit NF-κB and 
downregulated the expression of IL-1β, IL-6, and iNOS (Jia et al., 2019). 
Isolated compounds from the polyprenylated acylphloroglucinols class 
were the most important contributors to the anti-inflammatory capacity 
of most Hypericum species, which have been largely associated with 
suppression of inflammatory mediators expression. Some of those iso-
lated compounds are Hyperberins A and B, Hyperbeanol F, H, and O, all 
isolated from H. beanie (Li et al., 2019a,b; Xu et al., 2019); 
Table 1 (continued ) 
Species Plant parts Country of 
collection 
Active ingredients Biological 
activity 
Bioactive effects References 
Anthraquinonoids, xanthones, 
benzophenone, phloroglucinol, 
flavonoids, sterol, and alkaloid 
Ethanolic extract inhibited proliferation of 
A375 human malignant melanoma cell line, 
with an IC50 value of 52.35 ± 0.17 μg 
mL− 1. 
Whole plant China Anthraquinonoids, xanthones, 
benzophenone, phloroglucinol, 
flavonoids, sterol, and alkaloid 
Anti- 
inflammatory 
Ethanolic extracts at 32.44 ± 1.21 μg mL− 1 
suppressed NO levels in LPS-induced RAW 
264.7 mouse macrophage cells. 





Aerial part Turkey Pseudohypericin, hypericin, 




Methanolic extract showed decrease in 
mouse-paw volume by 78.0 % and 40.44 % 
after 1 h and 3 h in vivo exposure, 
respectively. 




Aerial part Turkey 
Phenolic acids, Flavonols and 
Flavones Anti-tyrosinase 
Methanolic extract showed tyrosinase 
inhibitory effect, with IC50 of 
65.35 ± 1.18 mg KAE/g extract. 
(Llorent-Martínez 
et al., 2018) 
Aerial part nm Polycyclic polyprenylated 
acylphloroglucinols 
Wound healing 
Hypermongone C cause significant 
migration of HDFs cells at 0.1 and 1 μg mL- 
1 over 18-h incubation. Cell viability was 
also maintained at the above tested 
concentrations. 
(Moghadam et al., 
2019) 
nm- not mentioned. 
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Hypermongone A, F, G, and H, and Furanmonogones A, isolated from 
the flowers of H. monogynum (Xu et al., 2017, 2015); Hypatulone A, 
isolated from H. patulum (Liu et al., 2018); and Norhypersampsone A, 
isolated from H. sampsonii (Zhang et al., 2017). Biomolecules belonging 
to other classes such as anthraquinonoids, xanthones, benzophenones, 
phenolic acids, and flavonoids, have also been identified as contributors 
to the anti-inflammatory activity of Hypericum species (Chen et al., 
2020; Jabeur et al., 2016; Nguyen Viet et al., 2019). A detailed 
anti-inflammatory overview was reported for hyperoside, a flavonol 
glycoside mainly found in plants of the genera Hypericum and Crataegus. 
Hyperoside at 10 μmol L− 1 maintained the viability of fibroblast-like 
cells, but a concentration-increased-treatment (100 μmol L− 1) reduced 
the cell viability by 27 %. The compound suppressed the production of 
TNFα, IL-6, and IL-1β in a concentration-dependent manner, while also 
suppressing nuclear translocation and phosphorylation of p65, and 
complete degradation of the IκBα complex (Jin et al., 2016). Hyperoside 
isolated from H. perforatum also reduce cytokine production, iNOS 
expression, and inhibited the activation of NF-κB by blocking Rel/p65 
translocation to the nucleus (Kim et al., 2011). Despite the interesting 
anti-inflammatory properties reported for these isolated compounds, 
their mechanism of action was not fully unveiled. The use of computa-
tional docking tools to simulate the affinity of these compounds can be 
further utilised to examine how they bind to the active sites of enzymes 
involved in the inflammation process. Najafizadeh et al. (2012) inves-
tigated the anti-psoriasis effects of a topical ointment containing extract 
of H. perforatum (5%). Ten patients (four men and six women aged be-
tween 20 and 55 years with mild plaque psoriasis) were selected and 
treated with H. perforatum ointment. The ointment was applied to each 
patient twice daily for 4 weeks, and the mean erythema scores (MRA), 
scaling scores (SC) and thickness scores (TC) before and after treatment 
were the evaluated parameters. The results showed that the modified 
Psoriasis Area Severity Index (PASI) ratings were significantly lowered. 
Additionally, MRA, SC TC were also significantly reduced from 2.6, 2.5, 
2.4 to 1.1, 0.7, 1.1, respectively. An ointment formulated with the 
extract of H. perforatum (5% wt/wt), vaseline (84 % wt/wt), propylene 
glycol (10 % wt/wt), and avicel (1% wt/wt) was reported by Mansouri 
et al. (2017) to suppress the severity of psoriasis. A double-blind, a 
placebo-controlled, and a pilot study were carried out in patients with 
mild to moderate plaque-type psoriasis. PASI scores, histological, and 
clinical changes were investigated after topical application of the oint-
ment. The results showed a reduction in erythema, scaling, and thick-
ness when compared to the placebo group. Similarly, clinical and 
histological features of treated lesions were improved. 
4.5. Wound healing activity 
Wound healing involves a series of complex biological processes that 
are controlled by different cell types such as the macrophages, dermal 
fibroblasts, epidermal keratinocytes, and the endothelial cells integrated 
in a well-orchestrated manner to repair the damaged skin. In general, 
the wound healing process comprises different overlapping steps such as 
inflammation, which is associated with the migration of immune cells to 
the wound area to prevent pathogen invasion, haemostasis, or blood 
clotting. Together with the proliferation and migration of fibroblasts, 
the development of new blood vessels (angiogenesis), and tissue reepi-
thelialisation (Moghadam et al., 2019). Wound treatment involves the 
use of topical antimicrobial and anti-inflammatory agents or a combi-
nation of both. Despite their widespread use, these drugs are associated 
with unwanted side effects and loss of therapeutic response, mainly 
antibiotic resistance. Hence, it is essential to find alternative ingredients 
with fewer side effects and active wound healing properties. Natural 
biomolecules have demonstrated wound healing properties mainly due 
to their potential to target multiple signalling pathways and effectively 
enhance fibroblast proliferation and migration, angiogenesis promotion, 
and suppression of inflammatory mediators overproduction (Beißner 
et al., 2018; Marrelli et al., 2019; Montoya et al., 2015). Extracts from 
H. androsaemum, H. perforatum, H. salsugineum, and H. scabrum have 
shown strong wound healing properties due to the structural diversity of 
their active ingredients, which synergistically interact to provide an 
overall healing effect (Antognoni et al., 2017; Bender et al., 2018; Dik-
men et al., 2010; Moghadam et al., 2019; Yücel et al., 2017). The wound 
healing activity of most Hypericum species, as shown in Table 1, have 
been associated with the stimulation of fibroblast migration, collagen 
production, suppression of inflammation, efficiently contributing to the 
wound closure of the damaged area and its reepithelialisation (Bridi 
et al., 2017; Moghadam et al., 2019; Süntar et al., 2011). The species 
exhibiting wound healing properties presented different levels of impact 
on the angiogenesis, inflammation, collagen production, fibroblast 
migration, and reepithelization parameters. Therefore, the combination 
of different extracts can assure a more efficient and stable response to-
wards healing. Regarding isolated compounds, only Moghadam et al. 
(2019) studied the potential of hypermongone C, a polycyclic poly-
prenylated acylphloroglucinol (PPAP), to accelerate wound healing 
through fibroblast migration, promotion of angiogenesis, and the sup-
pression of pro-inflammatory cytokines release. Hypermongone C 
(10 μg mL− 1) 24 h exposure maintained HDF cell viability up to 65 %. At 
the nontoxic concentrations, the compound induced migration of HDF 
cells towards the cell-free gap, revealing a remarkable 80 % closure 
when compared to the 45 % obtained by the control (untreated cells). 
Cell viability and cytotoxicity assays were performed to evaluate 
hyperforin concentrations presenting fewer toxic effects and; therefore, 
safer for topical application (Füller and Müller-Goymann, 2018). 
Hyperforin concentrations ranging from 0.05 to 1 μM did not reduce the 
viability of HDF; whereas, at 10 μM, the cell viability was suppressed by 
75 %. Additionally, after a 24 h exposure, there was no increase in HDF 
cells caspase activity, which demonstrates that hyperforin did not 
induce apoptosis of these cell line. The authors couldn’t demonstrate the 
wound healing potential of isolated hyperforin, which suggests that the 
wound healing effect of Hypericum extracts might be associated with the 
synergistic effect of their different constituents. Giudice et al. also 
confirmed the wound healing activity of a phytocosmetic formulations 
prepared from the aerial parts of H. perforatum either alone or in com-
bination with other plant-derived bioactive components (Giudice et al., 
2017). The authors reported a significant improvement in horses skin 
lesions of different breeds, age, and attitude. This healing capacity was 
attributed to the antibacterial, antioxidant, and anti-inflammatory 
properties of the ointment. H. perforatum gel also exerted significant 
positive effects (p < 0.05) in the wound healing of Wistar rats, when 
compared to the placebo group (Castro et al., 2012). The improvements 
were associated with tissue reepithelialisation, the formation of new 
blood vessels, and an increase in collagen fibres levels. Interesting 
findings for an H. perforatum ointment against linear incisions, circular 
excisions, and thermal burns were reported by Irina Prisăcaru et al. 
(2013). The authors described a significant improvement in wound 
contraction rate and a faster period of reepithelialisation. Most findings 
have identified that bioactive molecules, extracts, and formulations of 
some Hypericum species play crucial roles in the management of chronic 
and infected wounds. However, the mechanism behind these properties 
remains poorly understood. Due to their lengthy historical application 
against inflammatory disorders, and their wound healing capacity, 
widely reported in Turkish medicine, a novel ointment formulation was 
developed. Süntar et al. (2011) utilised extracts from H. perforatum, 
Origanum majorana L., Origanum minutiflorum Schwrd., and Salvia triloba 
L. The authors reported its wound capacity both in linear and circular 
incision wound models. The topical application of the ointment onto the 
incised wounds demonstrated the best injury tensile strengths, up to 
33.3 % on day 10, while the wound contractions were respectively 45.9 
%, 74.8 %, and 91.8 % on days 8, 10, and 12. The final formulation was 
not able to reduce elastase activity in vitro, but it displayed 
anti-collagenase activity in a concentration-dependent manner with an 
IC50 value of 7.4 ± 1.1 mg mL− 1. 
Recent findings have involved the development of active wound 
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dressing materials, capable of protecting the wound from microor-
ganism and ensure effective closure. There are various pathways for 
their development, mainly requiring incorporation of bioactive mole-
cules into wound dressing materials such as collagen, alginate, hyal-
uronic acid, chitosan, fucoidan, and Poly-N-acetyl glucosamine; thereby, 
ensuring their controlled release (Güneş and Tıhmınlıoğlu, 2017). This 
strategy is a practical approach to control inflammation, prevent in-
fections, as well as promote tissue regeneration. In the last few years, 
different nano and microparticulate formulations have been designed in 
the form of spheres and capsules. Various polymeric matrices (solid and 
liquid lipids) were used to encapsulate bioactive molecules for medical, 
cosmetic, and pharmaceutical applications (Battaglia and Ugazio, 2019; 
Vieira et al., 2020). These particles are dynamic and versatile delivery 
tools, offering advantages such as high kinetic stability, rigid 
morphology, high loading capacity, and high encapsulation efficiency. 
Concerning lipid-based nanoparticles, their production costs are low, 
with biodegradable materials that are of GRAS status (generally recog-
nised as safe); thereby, enhancing their potential large-scale industrial 
production without the use of organic solvents (Souto et al., 2020a, 
2020b). 
Nanotechnology has played a role in promoting the wound healing 
process. The encapsulated bioactive ingredients and some of the poly-
meric materials exhibit potent antimicrobial, anti-inflammatory, and 
pro-angiogenic properties (Naderi et al., 2018). Hypericin is a potent 
photosensitiser identified in most Hypericum species. However, due to its 
lipophilic properties, its utilisation in therapeutic applications is limited. 
Accordingly, Nafee et al. (2013) developed a biodegradable nanocarrier 
for hypericin using Polyethyleneglycol (PEG) and Polycaprolactone 
(PCL) copolymers, using a nanoprecipitation method in the absence of 
an emulsifier. The produced nanoparticles exhibiting uniform mono-
modal size distribution were found to inhibit MRSA. In vivo wound 
healing assays on Wistar rats revealed faster healing, with a significant 
reduction in wound diameter (~80 %) after 10 days, better epithelial-
ization, keratinization, and the development of collagen fibres. 
H. perforatum oil, at different concentrations (0.25–1.5 % v/v), was 
incorporated into chitosan films produced by solvent casting method as 
a potential wound dressing material. The Chitosan-based films pre-
sented no cytotoxic effects in NIH3T3 fibroblast cells, enhancing their 
proliferation (Güneş and Tıhmınlıoğlu, 2017). The results also showed 
that the chitosan films inhibited the growth of Escherichia coli and 
Staphylococcus aureus, making it a potential biomaterial for wound 
healing applications. Recently, Eğri et al. (2020) reported a better 
wound healing property for capsules with H. perforatum oil core formed 
by electrospinning PEG and PCL. The cell viability of the capsules in 
L929 mouse fibroblast cells was maintained, which is an indication of 
the biocompatibility and safety of the membranes. The controlled 
release of the active ingredients occurred due to the dissolution of PEG 
capsules, causing a significant decrease in the wound in vivo. Addition-
ally, the expressions of collagen type I and III proteins were increased in 
comparison with the placebo group. Histopathologically, a shortened 
healing period was also observed. Liposomal encapsulation of hypericin 
was also mentioned as being a promising solution for antimicrobial 
photodynamic therapy, a new therapeutic strategy to fight microbial 
resistance (Plenagl et al., 2018). MultiSal™ Skin Repair is a product 
from Salvona that utilises a “smart” encapsulation system to release 
multiple ingredients (H. perforatum extract and other active principles) 
in a gradual and sustained manner. The supplied elements help in skin 
repair and skin rejuvenation. To the authors’ best knowledge, this is the 
only commercial product with microencapsulated Hypericum in-
gredients in the market. 
4.6. Cytotoxicity and photodynamic therapy 
Long term exposure to UV radiation has been identified to be among 
the risk factors leading to skin cancer. UVR is involved in the ini-
tiation‑promotion‑progression steps of carcinogenesis, which is 
mediated through various cellular, biochemical, and molecular cascades 
(Ramasamy et al., 2017). The activation of these complex cascades of 
events favour tumour progression and invasion; therefore, there is an 
increasing need to find robust, multi-target, and multifunctional in-
gredients against UVR‑induced skin cancers. Most findings to date are 
associated with in vitro investigations in cell culture models such as 
keratinocytes, melanocytes, and fibroblast (Marques and MacNeil, 
2016). Some studies have identified extracts from Hypericum species 
(H. androsaemum, H. brasiliense, H. canariense, H. grandifolium, 
H. reflexum, and H. sampsonii) as being interesting bioactive compounds 
with potent cytotoxic properties, mainly against melanoma cells of 
human origin (A375 and UACC-62 human malignant melanoma cell 
lines) (Caprioli et al., 2016; Chen et al., 2020; França et al., 2013; Zor-
zetto et al., 2015). The investigated cytotoxic compounds are mostly 
phloroglucinols (hyperforatin F, japonicin, uliginosin, and isouliginosin 
B) and anthraquinonoids (emodin). Photodynamic therapy (PDT) is a 
novel, non‑invasive therapeutic strategy used to destruct various cells 
and tissues. It regarded as a topic of current interest, mainly in the area 
of dermato-oncology. The basic principle of the photodynamic therapy 
(PDT) involves the local or systemic application of a photosensitizer 
(PS), a light-sensitive substance which generates cytotoxic species. 
These include lethal levels of singlet oxygen and reactive oxygen species 
(ROS) upon irradiation, thereby leading to the destruction of cellular 
targets through direct cellular damage, vascular shutdown, and activa-
tion of an immune response against the targeted cells (Kim et al., 2018; 
Lima et al., 2013; Tampa et al., 2019). Sharma and Davids validated the 
efficacy of hypericin-mediated photodynamic-induced cell death 
(Sharma and Davids, 2012). The authors reported that the viability of 
both a human pigmented melanoma (UCT Mel-1) and an unpigmented 
melanoma (A375) cell line were suppressed after exposure to UVA (1 J 
cm− 2) treated with hypericin (3 μM). Kleemann et al. (2014) also re-
ported similar findings; these authors established that light-induced 
hypericin resulted in the photo destruction of the mitochondria and 
the endoplasmic reticulum of both UCT Mel-1 and A375 melanoma cells 
by compromising their membrane integrity, cell shrinkage, and finally, 
apoptosis. Additionally, the proliferative capacity of keratinocytes and 
fibroblast cells were enhanced after exposure to the extracts or isolated 
compounds obtained from Hypericum species (Table 1). Following the 
successful application of nanocarriers in various fields, hypericin-loaded 
solid lipid nanoparticles (Hy-SLN) were prepared using the ultra-
sonication technique by Lima et al. (2013). The produced nanoparticles 
were found to exhibit high encapsulation efficiency (80 %) and drug 
loading capacity 5.22 % (w/w). Photodynamic therapy against B16-F10 
mouse melanoma cell line proved that the hypericin-loaded nano-
particles presented better efficiency and cytotoxic effect when compared 
to free hypericin. These findings have shown the interesting skin cancer 
treatment properties of these biomolecules, without significantly giving 
any cytotoxic effect. 
The results mentioned above have shown the interesting skin cancer 
treatment properties of these biomolecules, with no significant cytotoxic 
effect (Bridi et al., 2019, 2017). 
4.7. Antimicrobial and preservative properties 
Preservatives are added to cosmetics to prevent microbiological 
contamination during manufacture, storage, but principally throughout 
the usage period (Herman, 2019). From raw ingredients to the final 
cosmetic products, microbial safety has become a critical issue to the 
cosmetic industry. According to the European Union (EU) legislation, 
the results of challenge tests across the entire production chain are 
mandatory elements of the individual Cosmetic Product Safety Report 
(Kočevar Glavač and Lunder, 2018). The most utilised strains in these 
tests are the well-recognised skin pathogens Pseudomonas aeruginosa, 
S. aureus, E. coli, Candida albicans, and Aspergillus brasiliensis. Although 
in the EU, only the regulated preservatives listed in Annex V (EC) can be 
used in cosmetics and personal care products; exposure to some of these 
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substances can produce skin irritation and sensitisation (Juliano and 
Magrini, 2018). Moreover, some studies recognise them as potential 
endocrine disruptors (Kerdudo et al., 2016; Kizhedath et al., 2019; 
Nohynek et al., 2013). These concerns, along with the increasing con-
sumer demand for natural ingredients guided cosmetic manufacturers 
into a continuous search for innovative and multifunctional natural 
biomolecules (Secchi et al., 2016). In the EU, the number of certified 
natural preservatives is minimal when compared to the list of the con-
ventional officially permitted, eight versus fifty-seven (Kočevar Glavač 
and Lunder, 2018). The main reasons behind these numbers discrepancy 
for natural preservatives are the absence of broad-spectrum activity, 
poor efficacy at low concentrations, unpleasant odour/colour, poor 
compatibility with other ingredients, irritation or allergenic potential, 
and cost. Despite these limitations, there is also an opportunity for re-
searchers and cosmetic manufacturers to combine different multifunc-
tional ingredients at lower concentrations, conferring a synergetic 
preservative effect on the product. The self-preserving approach in 
cosmetics has emerged in recent years. This method replaces traditional 
preservatives with cosmetic ingredients presenting multifunctional 
properties, which are primarily used as bioactive constituents for their 
positive effects on the skin but can also significantly contribute to the 
total preservative function (Kerdudo et al., 2016; Kočevar Glavač and 
Lunder, 2018; Varvaresou et al., 2009). P-anisic acid (masking), ethanol 
(solvent), glyceryl caprylate (emollient and emulsifying), grapefruit 
seed extract (masking and perfuming), Lactobacillus ferment (skin 
conditioning), and levulinic acid (perfuming and skin conditioning) are 
some of the functional ingredients with preservative properties 
approved by the EU and available at the CosIng database (Kočevar 
Glavač and Lunder, 2018). Plant-derived compounds vary in structure 
and chemical composition and can inhibit the growth and activity of 
many microorganisms. Recent studies have shown that phytochemicals 
exert their antibacterial activity through different mechanisms, such as 
damage to the bacterial membrane; suppression of virulence factors; 
inhibition of enzymes and toxins activity; and suppression of bacterial 
biofilm formation (Barbieri et al., 2017; Takó et al., 2020). Hypericum 
species possess a complex spectrum of bioactive molecules, which have 
been utilised as cosmeceutical ingredients due to their anti-ageing, 
photoprotective, wound healing, anti-inflammatory, and 
anti-tyrosinase properties. Additionally to the above-mentioned bioac-
tive properties, some Hypericum species and their metabolites; in 
particular phloroglucinols, anthraquinones, xanthones, and tannins 
have also been reported as exhibiting a broad-spectrum antimicrobial 
activity (Nogueira et al., 2013; Saddiqe et al., 2010). In this context, the 
structural diversity and multifunctional properties presented by Hyper-
icum species, underline them as feasible alternatives to replace synthetic 
cosmetic preservatives and antimicrobial substances to treat different 
skin problems associated with microorganisms overgrowth. Among the 
Hypericum genus, potent antifungal molecules have been identified in 
chloroform and methanolic extracts of H. garciae Pierce. The extracts 
displayed activity against a panel of clinical Candida isolates (C. albicans, 
C. parapsilosis, C. lusitaniae, C. tropicalis, C. intermedia, and C. glabrata), 
exhibiting results comparable to the MIC values obtained for flucona-
zole, a medicine widely used to treat fungal infections (Tocci et al., 
2018). While most antimicrobial screenings are performed against 
common skin pathogens such as Staphylococci species, P. aeruginosa, and 
C. albicans, skin dermatophytes like Trichophyton mentagrophytes and 
Microsporum canis have been overlooked. This lack of information has 
been associated with the challenges of culturing these microbes and 
their resistance phenomena (Aneke et al., 2018). The broad-spectrum 
anti-microbial properties of dichloromethane-methanol and aqueous 
extracts prepared from H. perforatum leaves were utilised against 
S. aureus, Methicillin-resistant S. aureus, S. epidermidis, P. aeruginosa, 
C. albicans, P. acnes, T. mentagrophytes, and M. canis to validate their 
properties as potential ingredients to treat common skin diseases such as 
ringworm infections and Acne vulgaris (Mabona et al., 2013). The ex-
tracts exhibited similar MICs to some of the most potent antibiotic and 
antifungal substances tested, Ciprofloxacin and amphotericin B, 
respectively. The ethanolic extract of Hypericum revolutum Vahl also 
presented a better MIC (31.25 μg mL− 1) against P. acnes when compared 
to the result obtained for the antibiotic tetracycline (56.26 ± 10.12 μg 
mL− 1) (Blom van Staden et al., 2017). The MICs reported for the ethanol 
extract of H. lydium Boiss against E. coli and S. aureus standard strains 
were >1024 μg mL− 1 and 16 μg mL− 1, respectively (Aygül and Şerbetçi, 
2020). It is interesting to note that gram-positive bacteria, such as 
S. aureus and Streptococcus pyogenes, and gram-negative bacteria like 
E. coli and P. aeruginosa, can both be found at an early stage or when a 
wound infection is fully developed (Moeini et al., 2020). Therefore, the 
antimicrobial properties of specific active secondary metabolites present 
in some Hypericum species strengthen their potential as wound healing 
components. 
Regarding isolated compounds, four dimeric Acylphloroglucinols 
isolated from the Hypericum japonicum whole plant, Hyperjaponicols 
A− D, displayed significant antibacterial activity, with MICs ranging 
from 0.8− 3.4 μM against E. coli and S. aureus. These results were com-
parable to cefotaxime sodium, a beta-lactam third-generation cephalo-
sporin antibiotic (Li et al., 2018). Hypericum extracts may be more active 
than the isolated components due to possible synergistic effects 
(Nogueira et al., 2013). 
The results above-compiled have shown that Hypericum species ex-
tracts and isolated compounds have potential to be used as antimicrobial 
and preservative agents due to their broad-spectrum antimicrobial ac-
tivity, which includes fungal strains, and gram-positive and negative 
bacteria. 
5. Safety and toxicity assessment 
The safety of extracts can be compromised due to the presence of one 
or more biomolecules. Therefore, knowledge of the molecules toxi-
cology present in the extract plays a pivotal role in establishing their 
safety. Most experimental studies conducted concerning the safety of 
extracts or isolated compounds obtained from Hypericum species are 
related to cell viability determination after exposure. Studies using 
different cell cultures of keratinocytes, melanoma, and fibroblast incu-
bated with Hypericum extracts or their isolated compounds have been 
utilised as useful models to determine the toxicity or the concentrations 
that would produce a toxic effect (Bridi et al., 2017; Gaid et al., 2019; 
Kurt-celep et al., 2020). Toxicity/safety data for most Hypericum species 
as cosmeceutical ingredients is significantly deficient due to the lack of a 
relevant pharmacological/toxicological approach. An expert panel 
reviewed the safety of seven H. perforatum derived ingredients 
(whole-plant extract, flower extract, flower/leaf extract, flower/-
leaf/stem extract, flower/twig extract, leaf extract, and H. perforatum 
oil) (Becker et al., 2014). H. perforatum extract (CAS No. 84082-80-4) 
and H. perforatum oil (CAS No. 68917-49-7) are used in the develop-
ment of several formulations, including skincare products, shampoos, 
and bath products. The Cosmetic Ingredient Review (CIR) Expert Panel 
evaluated the acute toxicity, including erythema, oedema formation, 
and changes in blood chemistry. The results showed that the active in-
gredients were not irritants or sensitizers, presenting no ocular irritation 
in the eye and genotoxicity. The authors concluded that the ingredients 
were safe for use in cosmetics and personal care products, even though 
no carcinogenicity, reproductive, and developmental toxicity data were 
available at the time. To the authors’ best knowledge, only H. perforatum 
among the several Hypericum species has been submitted to these 
detailed toxicological studies to determine their safe use as cosmetic 
ingredients. 
6. Hypericum-derived products 
6.1. Patents 
Investments in R&D activities are also related to the expectation of 
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obtaining intellectual rights over innovative findings and results; this is 
no less true for research on several Hypericum species and their related 
compounds application as cosmetic or cosmeceutical ingredients. Sci-
entific evidence in the literature has shown the vast cosmeceutical po-
tential of Hypericum species. However, these findings are still a long way 
from translating into commercially available products and as such, 
patent publications serve as essential resources to register the innova-
tion and protect their inventors. Comprehensive analysis on the patent 
technologies produced in the last decade (Espacenet®, PatentScope®, 
and Google Patents®) using the keyword Hypericum, and concerning 
cosmetics and cosmeceuticals, are presented in Table 2. The majority of 
Hypericum patent technologies related to cosmetic and cosmeceutical 
applications belong to H. perforatum species. The growing power of 
Asian traditional medicine, as well as its large population, makes this 
region highly relevant in novel cosmeceutical technologies. Besides, 
countries such as Spain, USA, Russia, and Latvia also presented inter-
esting patent technologies related to Hypericum because of the multi-
functional bioactive properties and potency of the Hypericum cultivars 
found in these countries. Most of the innovative technologies shown in 
Table 2 is related to the development of natural-based cosmetic 
Table 2 
A decade summary of some Hypericum species patented as cosmetic ingredients.  




Hypericum species or 
isolated metabolites 
Patent Tittle Patent Brief Details 
US9238153B2 
USA 
2016 Hypericin (H. 
perforatum) 
Transoral methods and compositions for wrinkle 
reduction and cosmetic lip and facial 
augmentation. 
This patent relates the anti-ageing potential of several natural 
ingredients as protective barriers to the ECM, specifically to 
reduce wrinkle appearance. 
KR20160048844A 
South Korea 
2016 H. perforatum Product comprising a plant for medicinal, 
cosmetic, colouring or dermatologic use. 
This patent relates to a product made from different plant 
extracts to suppress skin surface cracks, dryness, skin 
exfoliation, and burn. The different plant extracts were also 




2018 H. erectum Anti-aging composition for external application 
and its manufacturing method. 
This invention relates to the utilisation of different plant 
extracts to improve skin appearances, reduce wrinkle 




2017 H. forrestii Topical skin care formulations comprising plant 
extracts 
This patent relates to the utilisation of plant extracts 
(H. forrestii) with multifunctional properties such as TNF-α, 
antioxidant, and tyrosinase inhibitors. 
KR101979462B1 
South Korea 
2019 H. perforatum Nanocapsules containing microemulsions. Polymer nanocapsule based delivery systems including 
microemulsions were developed using hydrophilic active 




2013 H. perforatum Lipid nanoparticles capsules Solid lipid nanoparticles (SLN) and nanostructured lipid 
carriers (NLC) were developed to encapsulated active 
ingredients from plants with strong healing, re- 
epithelialization, anti-inflammatory and antioxidant properties 
US9056063B2 
USA 
2015 H. perforatum Natural sunscreen composition Because certain natural ingredients are known to have 
sunscreen properties, this patent describes different sunscreen 
formulations with natural extracts up to 0.001− 36%w, 
prepared from cosmetically acceptable ingredients. 
KR20120058830A 
South Korea 
2012 H. perforatum Cosmetic composition to promote the stemness 
of adipose-derived stem cells and proliferating 
skin cell containing Hypericum extracts. 
This patent describes an active principle containing a Hypericum 
extract as stem cell growth and skin cell proliferation 




2017 H. hirsutum Cosmetic skin whitening compositions 
containing extracts derived from in vitro 
propagated H. hirsutum. 
This invention describes the skin whitening potential of a 
hydroethanolic extract derived from in vitro (shoot cultures 
with no growth regulators added) cultivated H. hirsutum. 
ES2416804A1 
Spain 
2013 H. perforatum Composition of natural products for topical 
application. 
This patent describes a topical formulation in the form of gel, 
emulsion, and cream functionalised with bioactive ingredients 
(Portulaca oleracea, H. perforatum, Triticum aestivum, Malva spp., 
Urtica urens, and Arnica montana), which can be used in burns, 




2018 H. perforatum Cosmetic composition against inflammation on 
skin for usage as part of the cosmetic products 
This patent describes a cosmetic formulation consisting of 
glycyrrhizic acid and/or its derivative, glycerin, and water- 




2017 H. perforatum External preparation for skin containing 
flavanone derivative 
This patent describes a topical preparation containing 
flavanone derivatives obtained from different plant extract with 
excellent wound healing properties and a strong remodelling 
action of the collagen fibre bundle. 
KR101965032B1 
South Korea 
2019 H. ascyron Cosmetic Composition comprising extract of 
Hypericum ascyron 
This invention describes a cosmetic preparation containing 
Hypericum extract as an active ingredient with strong 
antioxidant, anti-hyaluronidase, anti-tyrosinase, anti- 
collagenase, and anti-elastase activity. The final formulation 




2013 H. perforatum Moisturising cream with solid lipid nanoparticles In this invention, a moisturising cream containing solid lipid 
nanoparticles with biologically active propylene glycol extracts 
of some medicinal plants. The final formulation improved skin 
water holding capacity and elasticity. 
CN104688610A 
China 
2015 H. monogynum Natural plant frozen film facial mask The invention relates to a beauty skincare product formulated 
with natural bioactive ingredients, which exhibit acne 
removing properties and a strong moisturizing capacity.  
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formulations with multifunctional properties. These effects include 
wrinkle reduction, skin exfoliation, maintenance of skin barrier func-
tion, the inhibition of inflammatory mediators, wound healing, UV 
protection, epidermal cell regeneration, and inhibition of tyrosinase, 
collagenase, and elastase. The numerous patents published in recent 
years cover a broad spectrum of potential cosmeceutical applications, 
which can further promote research and innovative opportunities. 
6.2. Commercial products 
Several commercial products formulated using extracts or isolated 
compounds obtained from Hypericum species are currently available in 
the market and utilised either to facial/body care and cleansing. Alpa-
flor® Hypericum B is a multifunctional cosmetic product from DSM 
nutritional products Ltd, Switzerland, formulated with H. perforatum 
extract and other key ingredients involved in the battle against inflam-
mation. It has anti-inflammatory, enzyme inhibitory, anti-microbial, 
radical-scavenging, and healing properties. Crodarom® ST John’s 
Wort O is produced by Crodarom S.A.S., a company specialised in 
botanical extracts for personal care and cosmeceuticals based in France. 
It is a phytocosmetic formulation containing extracts from H. perforatum 
and Olea europaea fruit oil extracts, which is responsible for soothing 
sensitive skin and suitable for dry skin. Phytoconcentrole® is an oil- 
based formulation containing H. Perforatum extract and functionalised 
with sunflower oil, soybean oil, and stabilisers. It is marketed by Sym-
rise, a company based in Germany with over 60 years of experience in 
developing high-quality natural ingredients for beauty and personal 
care. Phytoconcentrole® helps to keep the skin smooth and induce the 
formation of a natural protective film due to its lipophilic components. 
Most commercial products formulated using extracts from Hypericum 
species involve H. perforatum, and as such, significant efforts must be 
made to improve the development of formulations derived from other 
Hypericum species. An exhaustive report in literature has identified 
species such as H. androsaemum, H. monogynum, H. olympicum, and 
H. scabrum, among others, as exciting cosmeceutical candidates due to 
their reported anti-inflammatory, wound healing, and anti-ageing 
properties. 
7. Concluding remarks and future perspectives 
The rising demand and increased awareness among consumers on 
the origin, safety, and environmental implications of some of the in-
gredients used in cosmetics and personal care products are stimulating 
the research on novel bioactive ingredients from natural sources. The 
current review was aimed at studying plants belonging to the Hypericum 
genus that present potential as cosmeceutical ingredients, together with 
a summary of the scientific evidence regarding their commercial 
exploitation. In the last decade, studies on the phytochemical compo-
sition and biological properties of several Hypericum species have been 
widely reported. Among them, H. perforatum was the most widely 
exploited concerning its chemical composition, biological properties, 
and potential use as cosmeceutical ingredients. Some of the multifunc-
tional properties reported for most Hypericum plants include anti- 
inflammatory, anti-tyrosinase, anti-collagenase, anti-elastase, UV pho-
toprotective, and wound healing. The main constituents of the Hyper-
icum species are naphthodianthrones, phloroglucinol derivatives, 
phenolic acids, and flavonoids. Despite this knowledge, studies eluci-
dating their mechanism of action and the bioactive metabolites 
responsible for some of the ascribed biological properties are still defi-
cient; therefore, more studies need to be conducted. One of the criteria 
postulated by Dr Albert Kligman, who regarded as the father of cos-
meceutical science states that, before classifying an active molecule as a 
cosmeceutical ingredient, data on the skin permeation and penetration 
into the stratum corneum should be established, and the bioavailable 
concentration determined to ensure it is enough to have the desired 
cosmeceutical effect. However, studies on the transdermal delivery of 
the active components found in different Hypericum species is also 
significantly lacking in the literature. In the past, ethical issues have 
significantly contributed to the scarcity of in vitro and in vivo skin 
permeation studies; however, with recent advancement in cell biology 
and tissue engineering, cell culture-based human skin models have been 
developed and are commercially available. They include reconstructed 
human epidermis and several skin equivalents models such as EpiSkin®, 
SkinEthic®, EpiDerm®, GraftSkin®, EpiDermFT®, and Pheninon®, 
among others. Skin permeation assessment is key to the successful 
development of new cosmeceutical formulation; and therefore, these 
models can be further utilised due to their strong in vivo correlation. 
Nanodelivery systems have been utilised as a distinctive and useful 
approach to overcome the limitations associated with natural bio-
molecules in cosmeceuticals. Several Hypericum derived ingredients 
have been loaded into nanocapsules and microparticles offering higher 
stability and improved efficacy, mainly in wound healing applications. 
Hence, new developments in other cosmeceutical areas such as anti-
aging and photoprotection, among others, could be further explored. 
The physical and chemical features of the skin are the support for a 
unique set of microorganisms, most of which are harmless or even 
beneficial to their host. Recent studies have suggested that aside from 
the gastrointestinal tract, skin harbours the most microbes in the human 
body; which implies that the composition of the skin microbiota can 
influence an individual’s skin health and condition, including skin 
ageing. Some studies have highlighted candidate microbes and func-
tional pathways that are important in preventing skin ageing and which 
could lead to a comprehensive understanding of age-related skin 
microbiome characteristics. Ample evidence has been emerging on the 
activity of natural biomolecules on the modulation of the skin microbial 
population composition or activity. Hence, further work could be per-
formed to understand the effect of Hypericum extracts and their isolated 
compounds as potential skin microbiome modulators; thereby, offering 
innovative dimension to this genus properties. The studies presented in 
this review reflect the enormous scientific findings that have been 
invested in the application of Hypericum species as sources of pharma-
cologically active metabolites for exploitation in the growing cosme-
ceutical industry. 
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Echeverri, F., Robledo, S.M., 2015. Development of a novel formulation with 
hypericin to treat cutaneous leishmaniasis based on photodynamic therapy in in vitro 
and in vivo studies. Antimicrob. Agents Chemother. 59, 5804–5813. https://doi.org/ 
10.1128/AAC.00545-15. 
Mukherjee, P.K., Biswas, R., Sharma, A., Banerjee, S., Biswas, S., Katiyar, C.K., 2018. 
Validation of medicinal herbs for anti-tyrosinase potential. J. Herb. Med. 14, 1–16. 
https://doi.org/10.1016/j.hermed.2018.09.002. 
Nabavi, S.M., Nabavi, S.F., Sureda, A., Caprioli, G., Iannarelli, R., Sokeng, A.J.T., 
Braidy, N., Khanjani, S., Moghaddam, A.H., Atanasov, A.G., Daglia, M., Maggi, F., 
2018. The water extract of tutsan (Hypericum androsaemum L.) red berries exerts 
antidepressive-like effects and in vivo antioxidant activity in a mouse model of post- 
stroke depression. Biomed. Pharmacother. 99, 290–298. https://doi.org/10.1016/j. 
biopha.2018.01.073. 
Naderi, N., Karponis, D., Mosahebi, A., Seifalian, A.M., 2018. Nanoparticles in wound 
healing; from hope to promise, from promise to routine. Front. Biosci. - Landmark 
23, 1038–1059. https://doi.org/10.2741/4632. 
Nafee, N., Youssef, A., El-Gowelli, H., Asem, H., Kandil, S., 2013. Antibiotic-free 
nanotherapeutics: hypericin nanoparticles thereof for improved in vitro and in vivo 
antimicrobial photodynamic therapy and wound healing. Int. J. Pharm. 454, 
249–258. https://doi.org/10.1016/j.ijpharm.2013.06.067. 
Najafizadeh, P., Hashemian, F., Mansouri, P., Farshi, S., Surmaghi, M.S., Chalangari, R., 
2012. The evaluation of the clinical effect of topical St Johns wort (Hypericum 
perforatum L.) in plaque type psoriasis vulgaris: a pilot study. Australas. J. Dermatol. 
53, 131–135. https://doi.org/10.1111/j.1440-0960.2012.00877.x. 
Napoli, E., Siracusa, L., Ruberto, G., Carrubba, A., Lazzara, S., Speciale, A., Cimino, F., 
Saija, A., Cristani, M., 2018. Phytochemical profiles, phototoxic and antioxidant 
properties of eleven Hypericum species – a comparative study. Phytochemistry 152, 
162–173. https://doi.org/10.1016/j.phytochem.2018.05.003. 
Natural Cosmetics Market Size, Share, Trends | Industry Report, 2025. https://www.gr 
andviewresearch.com/industry-analysis/natural-cosmetics-market. 
Nguyen Viet, D., Le Ba, V., Nguyen Duy, T., Pham Thi, V.A., Tran Thi, H., Le Canh, V.C., 
Bach Long, G., Kim, Y.H., Tuan, Anh, Le, H., 2019. Bioactive compounds from the 
aerial parts of Hypericum sampsonii. Nat. Prod. Res. 0, 1–3. https://doi.org/10.1080/ 
14786419.2019.1586690. 
Nogueira, T., Medeiros, M.A., Marcelo-Curto, M.J., García-Pérez, B.E., Luna-Herrera, J., 
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